Glaxo presses on to find the next critical antibiotic
Despite the rise of superbugs, big pharma has largely exited antibiotic research because of low payoff
Thu, Sep 22, 2016 - 5:50 AM
Penicillin changed the world; infections that previously killed people were now treatable, paving the way for safer operations from organ transplants to hip replacements.
IN A cramped lab in rural Penn-sylvania, surrounded by technicians in obligatory white lab coats and fume hoods leaking an occasional acrid smell, Neil Pearson holds up a plastic model of a chemical compound that resembles a spidery piece of Lego.